Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28876299 | 0.78 | — | — | |
| SCHEMBL29009347 | 0.74 | — | — | |
| SCHEMBL2283117 | 0.70 | HDAC4 (0.34) | MAOAMAOBTAAR1HDAC4 | |
| SCHEMBL8039521 | 0.68 | PNMT (0.39) | MAOAMAOBTAAR1 | |
| SCHEMBL27449113 | 0.68 | HDAC4 (0.33) | MAOAMAOBTAAR1HDAC4 | |
| SCHEMBL3357684 | 0.67 | HDAC4 (0.36) | HDAC4 | |
| SCHEMBL16163009 | 0.67 | HDAC4 (0.32) | HDAC4 | |
| SCHEMBL5715764 | 0.67 | MAOB (0.38) | MAOAMAOBHDAC4 | |
| SCHEMBL276639 | 0.67 | HDAC4 (0.32) | HDAC4 | |
| SCHEMBL4089733 | 0.67 | HDAC4 (0.36) | MAOAMAOBHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050038289-A1 | Chemical reactions in compressed carbon dioxide | GORDON RICHARD S (GB) | 2005-02-17 | — | — | US | claimed |
| EP-1409131-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | Holmes, Andrew Bruce (GB) | 2004-04-21 | — | — | EP | claimed |
| WO-2003009936-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | HOLMES ANDREW BRUCE (GB) | 2003-02-06 | — | — | WO | claimed |
| WO-2025087365-A1 | METTL3 INHIBITOR | 杭州邦顺制药有限公司 | 2025-05-01 | — | — | WO | disclosed |
| US-20050038289-A1 | Chemical reactions in compressed carbon dioxide | GORDON RICHARD S (GB) | 2005-02-17 | — | — | US | disclosed |
| US-20050038289-A1 | Chemical reactions in compressed carbon dioxide | GORDON RICHARD S (GB) | 2005-02-17 | — | — | US | disclosed |
| EP-1409131-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | Holmes, Andrew Bruce (GB) | 2004-04-21 | — | — | EP | disclosed |
| EP-1409131-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | Holmes, Andrew Bruce (GB) | 2004-04-21 | — | — | EP | disclosed |
| WO-2003009936-A3 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | HOLMES ANDREW BRUCE (GB) | 2003-08-21 | — | — | WO | disclosed |
| WO-2003009936-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | HOLMES ANDREW BRUCE (GB) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003009936-A2 | PALLADIUM-CATALYSED CARBON-CARBON BOND FORMING REACTIONS IN COMPRESSED CARBON DIOXIDE | HOLMES ANDREW BRUCE (GB) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038289-A1 | Chemical reactions in compressed carbon dioxide | TERT, TXK, CHKB | MAOA 2016/4885MAOB 1390/4885TAAR1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.